OpGen, Inc. (OPGN)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Sep 15, 2025, 10:04 AM EDT
OpGen Employees
OpGen had 1 employees as of December 31, 2024. The number of employees decreased by 99 or -99.00% compared to the previous year.
Employees
1
Change
-99
Growth
-99.00%
Revenue / Employee
$5,196,149
Profits / Employee
$11,356,038
Market Cap
1.01K
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1 | -99 | -99.00% |
| Dec 31, 2022 | 100 | 1 | 1.01% |
| Dec 31, 2021 | 99 | -11 | -10.00% |
| Dec 31, 2020 | 110 | 70 | 175.00% |
| Dec 31, 2019 | 40 | -10 | -20.00% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Elite Pharmaceuticals | 68 |
| Tian'an Technology Group | 8 |
| Glass House Brands | 374 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| American Oncology Network | 1,914 |
| Silence Therapeutics | 116 |
OpGen News
- 1 year ago - OpGen Receives Expected Nasdaq Notice Regarding Delayed Form 10-Q - GlobeNewsWire
- 1 year ago - OpGen Announced 1-for-10 Reverse Stock Split - GlobeNewsWire
- 1 year ago - OpGen Provides Update on Business Operations and Strategic Opportunities - GlobeNewsWire
- 1 year ago - OpGen Receives Nasdaq Notice Regarding Delayed Form 10-K - GlobeNewsWire
- 1 year ago - OpGen Announces Acquisition of Preferred Stock by David Lazar - GlobeNewsWire
- 1 year ago - OpGen Reports Third Quarter 2023 Financial Results and Provides Business Update - GlobeNewsWire
- 2 years ago - OpGen Enters Into Warrant Inducement Transaction for up to $11.2 Million in Gross Proceeds - GlobeNewsWire
- 2 years ago - OpGen, Inc. (OPGN) Q2 2023 Earnings Call Transcript - Seeking Alpha